Skip to content
PubMed This is a summary of 98 peer-reviewed journal articles Updated
Pediatric neurology

X-Linked Intellectual Disability-Hypotonia-Movement Disorder Syndrome: A Patient Guide

At a Glance

X-linked intellectual disability-hypotonia-movement disorder syndrome is an umbrella term for several genetic conditions. Identifying the specific gene helps clinicians tailor monitoring, therapies, and support to a child’s needs.

Important Note: This guide covers a broad clinical phenotype. Symptoms alone cannot identify the causal gene or predict inheritance. X-linked intellectual disability-hypotonia-movement disorder is an “umbrella” term for several distinct genetic conditions, each with its own specific monitoring and care needs.

X-linked intellectual disability-hypotonia-movement disorder syndrome is a clinical descriptive term for a complex neurodevelopmental condition characterized by three core challenges. This “triad” of symptoms includes intellectual disability, which affects how a child learns and solves problems; hypotonia, a state of low muscle tone that often presents as “floppiness” in infancy; and movement disorders, which involve involuntary or uncoordinated physical actions like twisting, shaking, or stiffness [1]. Because these symptoms involve the brain’s communication with the rest of the body, they impact many aspects of a child’s development, from their first motor milestones to how they eventually interact with the world around them [2].

The condition is rooted in the biology of the X chromosome. Because it is X-linked, the syndrome often affects males, who have only one X chromosome and therefore may lack a compensating copy for the affected gene, though females can also be affected depending on the exact condition [3]. While some families may have a history of these traits, many cases arise de novo, meaning the genetic change occurred for the first time in the child [4]. It is important for parents to understand that these changes are natural biological events; they are not caused by any lifestyle choices or actions taken during pregnancy [5].

While the syndrome’s name describes what is happening clinically, it actually serves as an “umbrella” for several distinct genetic conditions. Identifying the specific gene involved—such as SLC16A2, WDR45, or IQSEC2—is a critical step in a child’s care journey [6]. A precise genetic diagnosis moves the conversation from general descriptions to a focused management plan, as different genes can lead to unique health needs, such as specific thyroid monitoring or different patterns of movement over time [2][7].

Living with this condition requires a proactive, multidisciplinary approach to care. This model brings together a team of specialists, including neurologists, geneticists, and therapists, who work in harmony to support the child’s unique path [8]. While the journey involves navigating lifelong challenges, the focus of modern medicine is on maximizing a child’s comfort, improving their ability to communicate, and ensuring they can participate fully in their family and community life [9]. Through early intervention and dedicated support, the goal is to empower each child to reach their individual potential.

Common questions in this guide

What is X-linked intellectual disability-hypotonia-movement disorder syndrome?
It is an umbrella term for several genetic neurodevelopmental conditions that can cause intellectual disability, low muscle tone (hypotonia), and involuntary or uncoordinated movements. The label alone does not identify one gene or predict a child’s inheritance pattern.
Why might my child need genetic testing for this syndrome?
Genetic testing may identify the specific gene involved, such as SLC16A2, WDR45, or IQSEC2. A specific diagnosis can help the care team choose monitoring and support that fit the child’s particular health and movement needs.
Does an X-linked diagnosis always come from a parent?
No. Some X-linked conditions are inherited and may occur in families, while many genetic changes arise de novo, meaning they are new in the child. These changes are not caused by a parent’s lifestyle or actions during pregnancy; a genetics professional can explain the family’s specific inheritance pattern.
What symptoms can this syndrome cause in a child?
The core features are intellectual disability, hypotonia (low muscle tone or infant floppiness), and movement problems. Movement symptoms can include twisting, shaking, stiffness, or other involuntary or uncoordinated actions, and the condition can affect motor and communication development.
Which specialists should care for a child with this syndrome?
Care is usually coordinated across a neurologist, a medical geneticist, and therapists who support physical and communication development. A pediatric movement-disorder neurologist may be useful when movement symptoms are prominent.
What treatments and support can help my child?
Early intervention and a multidisciplinary care plan can support physical development, communication, comfort, and participation in family and community life. Therapists and medical specialists can adjust goals as the child’s needs change.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on X-linked intellectual disability-hypotonia-movement disorder syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which of the specific genetic conditions under this umbrella does my child's testing suggest?
  2. 2.How will our care team coordinate between the neurologist, geneticist, and therapists to manage these three different types of symptoms?
  3. 3.What are our primary goals for my child's physical and communication development over the next six months?
  4. 4.Are there specific specialists, such as a pediatric movement disorder neurologist, whom we should add to our core team?

References

References (9)
  1. 1

    Biallelic MED27 variants lead to variable ponto-cerebello-lental degeneration with movement disorders.

    Maroofian R, Kaiyrzhanov R, Cali E, et al.

    Brain : a journal of neurology 2023; (146(12)):5031-5043 doi:10.1093/brain/awad257.

    PMID: 37517035
  2. 2

    Expanding the phenotypic spectrum of Allan-Herndon-Dudley syndrome in patients with SLC16A2 mutations.

    Remerand G, Boespflug-Tanguy O, Tonduti D, et al.

    Developmental medicine and child neurology 2019; (61(12)):1439-1447 doi:10.1111/dmcn.14332.

    PMID: 31410843
  3. 3

    Two novel DNA variants associated with glucose-6-phosphate dehydrogenase deficiency found in Argentine pediatric patients.

    Chaves A, Eberle SE, Defelipe L, et al.

    Clinical biochemistry 2016; (49(10-11)):808-10.

    PMID: 26827633
  4. 4

    NEXMIF encephalopathy: an X-linked disorder with male and female phenotypic patterns.

    Stamberger H, Hammer TB, Gardella E, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2021; (23(2)):363-373 doi:10.1038/s41436-020-00988-9.

    PMID: 33144681
  5. 5

    Use of targeted next-generation sequencing for molecular diagnosis of craniosynostosis: Identification of a novel de novo mutation of EFNB1.

    Yamamoto T, Igarashi N, Shimojima K, et al.

    Congenital anomalies 2016; (56(2)):91-3 doi:10.1111/cga.12123.

    PMID: 26208246
  6. 6

    Genetic and metabolic investigations for neurodevelopmental disorders: position statement of the Canadian College of Medical Geneticists (CCMG).

    Carter MT, Srour M, Au PB, et al.

    Journal of medical genetics 2023; (60(6)):523-532 doi:10.1136/jmg-2022-108962.

    PMID: 36822643
  7. 7

    Quantitative retrospective natural history modeling of WDR45-related developmental and epileptic encephalopathy - a systematic cross-sectional analysis of 160 published cases.

    Saffari A, Schröter J, Garbade SF, et al.

    Autophagy 2022; (18(7)):1715-1727 doi:10.1080/15548627.2021.1990671.

    PMID: 34818117
  8. 8

    Clinical and Biochemical Monitoring of Monocarboxylate Transporter 8 Deficiency (Allan-Herndon-Dudley Syndrome) across the Lifespan: Practical Considerations for Multidisciplinary Care.

    Dietrich JW, Jelesch E, Linder-Lucht M, et al.

    Hormone research in paediatrics 2026; 1-14 doi:10.1159/000551857.

    PMID: 41926547
  9. 9

    Patients with Allan-Herndon-Dudley Syndrome (MCT8 Deficiency) Display Symptoms of Parkinsonism in Childhood and Respond to Levodopa/Carbidopa Treatment.

    Wilpert NM, Hewitt AL, Pons R, et al.

    Movement disorders : official journal of the Movement Disorder Society 2025; (40(5)):938-949 doi:10.1002/mds.30152.

    PMID: 40088079

This guide explains the umbrella term X-linked intellectual disability-hypotonia-movement disorder for informational purposes only and does not constitute medical advice. A clinical geneticist and your child’s care team should interpret testing and plan individualized monitoring.